Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Murphy, MD
Northwestern University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundacion Huesped Clinical Research
Buenos Aires, Argentina
- Instituto Nacional de Nutricion
Mexico City, Mexico
- Medical Research Center Consultorio Royal Center
Republico de Panama, Panama
- Northwestern University
Chicago, Illinois, United States
- Jacobi Medical Center
The Bronx, New York, United States
- Burnside Clinic
Columbia, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2004
- Primary completion
- —
- Completion
- 31 Mar 2006
- Last update posted
- 3 Jul 2007
- Registered enrollment
- 60
- Registry id
- NCT00121979
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.